366
Participants
Start Date
November 26, 2018
Primary Completion Date
February 5, 2021
Study Completion Date
February 5, 2021
PF-06651600
Induction dose 1. Oral tablet taken QD
PF-06651600
Induction dose 2. Oral tablet taken QD
PF-06651600
Maintenance dose A. Oral tablet taken QD
PF-06651600
Maintenance Dose B. Oral tablet taken QD
PF-06651600
Maintenance Dose C. Oral tablet taken QD
placebo
placebo
PF06700841
Oral tablet taken QD
narrow-band UVB phototherapy
Phototherapy will be combined with PF-06651600
Hôpital Erasme Dermatology, Brussels
UZ Brussel - Dermatology, Brussels
The Skin Hospital, Darlinghurst
Premier Specialists Pty Ltd, Kogarah
Sinclair Dermatology, East Melbourne
The Royal Melbourne Hospital, Parkville
The Royal Melbourne Hospital, Parkville
Skin Health Institute, Carlton
Veracity Clinical Research Pty Ltd, Woolloongabba
UZ Gent - Dermatology, Ghent
National Taiwan University Hospital, Taipei
Icahn School of Medicine at Mount Sinai, New York
Upper West Side Dermatology c/o TrialSpark, Inc, New York
MDCS: Medical Dermatology & Cosmetic Surgery (TrialSpark, Inc.), New York
Dongguk University Ilsan Hospital, Goyang-si
South Nassau Dermatology, Oceanside
TrialSpark, Inc. - Russell W. Cohen, MD, Oceanside
Hospital Universitario Reina Sofia, Córdoba
The Catholic University of Korea, St. Vincent's Hospital, Suwon
Ajou University Hospital, Suwon
Chevy Chase Dermatology Center (TrialSpark, Inc.), Chevy Chase
TrialSpark - Samantha Toerge, MD, Chevy Chase
TrialSpark - Ronald Shore, MD, Rockville
Tamjidi Skin Institute (TrialSpark, Inc.), Vienna
Inha University Hospital, Incheon
Virginia Clinical Research, Inc, Norfolk
Universitaetsklinikum Schleswig-Holstein, Campus Luebeck CCIM, Lübeck
Hospital Universitario Ramón y Cajal, Madrid
Hospital Universitario La Paz, Madrid
PMG Research of Wilmington, LLC, Wilmington
Park Avenue Dermatology, Orange Park
New Horizon Research Center, Miami
ForCare Clinical Research, Tampa
Remington-Davis, Inc. Clinical Research, Columbus
ForeFront Dermatology, Columbus
Hospital Universitari i Politecnic La Fe, Valencia
Universitaetsklinikum Muenster, Münster
Henry Ford Hospital Department of Dermatology, Detroit
Fachklinik Bad Bentheim, Fachbereich Dermatologie und Allergologie, Dermatologische Ambulanz, Bad Bentheim
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz, Mainz
University of Minnesota Department of Dermatology, Minneapolis
Universitätsklinikum Frankfurt, Klinik für Dermatologie, Venerologie und Allergologie, Frankfurt am Main
Advanced Skin and MOHS Surgery Center, c/o TrialSpark, Inc., Chicago
National Cheng Kung University Hospital, Tainan City
Vital Prospects Clinical Research Institute, PC, Tulsa
Pickens Academic Tower, Houston
The University of Texas Health Science Center at Houston, Houston
The University of Texas MD Anderson Cancer Center, Houston
University Physicians Group, Austin
Chang Gung Medical Foundation - Kaohsiung Chang Gung Memorial Hospital, Kaohsiung City
Vitiligo and Pigmentation Institute Of Southern California, Los Angeles
Universitaetsklinikum Erlangen Hautklinik Studienambulanz, Erlangen
Dermatology Specialists, Inc., Oceanside
Dermatology Specialist, Inc., Murrieta
Marvel Research, LLC, Huntington Beach
University of California, Irvine, Dermatology Clinical Research Center, Irvine
UC Davis Health, Sacramento
Brookside Dermatology Associates, Bridgeport
New England Research Associates, LLC, Bridgeport
Tobias & Battite, Inc., Boston
Tufts Medical Center, Boston
UMass Memorial Medical Center, Hahnemann Campus, Worcester
Investigational Drug Service Pharmacy, Worcester
UMass Memorial Medical Center Ear Nose and Throat, Worcester
University of Massachusetts Medical School, Worcester
The Dermatology Group, P.C., Verona
University of Texas Southwestern Medical Center, Dallas
Dr. Chih-ho Hong Medical Inc., Surrey
Enverus Medical Research, Surrey
University of British Columbia, Vancouver
Wiseman Dermatology Research Inc., Winnipeg
CCA Medical Research, Ajax
Guenther Research Inc., London
Lynderm Research Inc., Markham
DermEdge Research, Mississauga
North York Research Inc., North York
The Centre for Clinical Trials, Oakville
The Centre for Dermatology, Richmond Hill
K.Papp Clinical Research, Waterloo
Innovaderm Research Inc., Montreal
Centre de Recherche Dermatologique du Quebec metropolitain (CRDQ), Québec
Centre de Recherche Saint-Louis, Québec
Centre de Recherche Saint-Louis, Québec
Diex Research Sherbrooke Inc., Sherbrooke
Istituti Fisioterapici Ospitalieri, Istituto di Ricovero e Cura a Carattere Scientifico,, Roma
Nagoya City University Hospital - Dermatology, Nagoya
Tohoku University Hospital, Sendai
Nippon Medical School Hospital, Bunkyo-ku
Tokyo Medical University Hospital, Shinjuku-ku
Yamanashi Prefectural Central Hospital, Kofu
Severance Hospital, Yonsei University Health System, Seoul
Hospital de la Santa Creu i Sant Pau, Barcelona
Lead Sponsor
Pfizer
INDUSTRY